Proyecto De Biomedicina Cima, S.l.

Javier Dotor De Las Herrerías

Juan José Lasarte Sagastibelza

Inés Noelia Casares Lagar

Francisco Borras Cuesta

Jesus Prieto Valtuena

Francisco Borrás Cuesta

Pablo Sarobe Ugarriza

Juan Jose Lasarte Sagastibelza

Nancy Díaz-Valdés Farray

Jesús Prieto Valtueñ

Ana Belen Lopez Vazquez

Lorea Manterola Careaga

The invention relates to peptides having the capacity to bind to interleukin-10 (IL-10) and their use in the treatment of clinical conditions or pathological disorders associated to IL-10 expression, particularly to a high IL-10 expression, for example, infectious diseases, tumors, cancers and acute damage conditions.

Peptides with capacity for binding with interleukine 10 (IL-10)

The described peptides possess the capacity to bind to Transforming Growth Factor TGF-&#x3b2;1 (TGF-&#x3b2;1), and are potential inhibitors of the biological activity of TGF-&#x3b2;1 through direct binding to this cytokine. These peptides can be used in the treatment of diseases or pathological alterations based on excessive or deregulated TGF-&#x3b2;1 expression.

Peptides with the capacity to bind to transforming growth factor &#x3b2;1 (TGF-&#x3b2;1)

Growing community of inventors

Pamplona-Navarra, Spain

Javier Dotor De Las Herrerías